Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Improved regional myocardial blood flow and flow reserve after coronary revascularization as assessed by serial 15O-water positron emission tomography/computed tomography.

Aikawa T, Naya M, Koyanagawa K, Manabe O, Obara M, Magota K, Oyama-Manabe N, Tamaki N, Anzai T.

Eur Heart J Cardiovasc Imaging. 2019 Sep 23. pii: jez220. doi: 10.1093/ehjci/jez220. [Epub ahead of print]

PMID:
31544927
2.

Development and characterization of EST-SSR markers for Saxifraga fortunei var. incisolobata (Saxifragaceae).

Magota K, Takahashi D, Setoguchi H.

Appl Plant Sci. 2019 Jul 9;7(7):e11275. doi: 10.1002/aps3.11275. eCollection 2019 Jul.

3.

Biodistribution and radiation dosimetry of the novel hypoxia PET probe [18F]DiFA and comparison with [18F]FMISO.

Watanabe S, Shiga T, Hirata K, Magota K, Okamoto S, Toyonaga T, Higashikawa K, Yasui H, Kobayashi J, Nishijima KI, Iseki K, Matsumoto H, Kuge Y, Tamaki N.

EJNMMI Res. 2019 Jul 5;9(1):60. doi: 10.1186/s13550-019-0525-6.

4.

Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer.

Kroenke M, Hirata K, Gafita A, Watanabe S, Okamoto S, Magota K, Shiga T, Kuge Y, Tamaki N.

PLoS One. 2019 Feb 28;14(2):e0213111. doi: 10.1371/journal.pone.0213111. eCollection 2019.

5.

["Zou u mij de komkommer aan kunnen geven?"]

Magota K.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018 Dec;74(12):1497-1501. doi: 10.6009/jjrt.2018_JSRT_74.12.1497. Japanese. No abstract available.

6.

Cardiac sarcoidosis classification with deep convolutional neural network-based features using polar maps.

Togo R, Hirata K, Manabe O, Ohira H, Tsujino I, Magota K, Ogawa T, Haseyama M, Shiga T.

Comput Biol Med. 2019 Jan;104:81-86. doi: 10.1016/j.compbiomed.2018.11.008. Epub 2018 Nov 12.

PMID:
30447397
7.

Novel anti-aging gene NM_026333 contributes to proton-induced aging via NCX1-pathway.

Osanai T, Tanaka M, Mikami K, Kitajima M, Tomisawa T, Magota K, Tomita H, Okumura K.

J Mol Cell Cardiol. 2018 Dec;125:174-184. doi: 10.1016/j.yjmcc.2018.10.021. Epub 2018 Oct 29.

PMID:
30385152
8.

Use of 18F-FDG PET/CT texture analysis to diagnose cardiac sarcoidosis.

Manabe O, Ohira H, Hirata K, Hayashi S, Naya M, Tsujino I, Aikawa T, Koyanagawa K, Oyama-Manabe N, Tomiyama Y, Magota K, Yoshinaga K, Tamaki N.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1240-1247. doi: 10.1007/s00259-018-4195-9. Epub 2018 Oct 16.

PMID:
30327855
9.

Early prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational study.

Takeuchi S, Shiga T, Hirata K, Taguchi J, Magota K, Ariga S, Gouda T, Ohhara Y, Homma R, Shimizu Y, Kinoshita I, Tsuji Y, Homma A, Iijima H, Tamaki N, Dosaka-Akita H.

BMJ Open. 2018 Aug 30;8(8):e021001. doi: 10.1136/bmjopen-2017-021001.

10.

Intracellular protons accelerate aging and switch on aging hallmarks in mice.

Osanai T, Tanaka M, Izumiyama K, Mikami K, Kitajima M, Tomisawa T, Magota K, Tomita H, Okumura K.

J Cell Biochem. 2018 Dec;119(12):9825-9837. doi: 10.1002/jcb.27302. Epub 2018 Aug 20.

PMID:
30129099
11.

Multicentre analysis of PET SUV using vendor-neutral software: the Japanese Harmonization Technology (J-Hart) study.

Tsutsui Y, Daisaki H, Akamatsu G, Umeda T, Ogawa M, Kajiwara H, Kawase S, Sakurai M, Nishida H, Magota K, Mori K, Sasaki M; J-Hart study group.

EJNMMI Res. 2018 Aug 20;8(1):83. doi: 10.1186/s13550-018-0438-9.

12.

Effects of coronary revascularization on global coronary flow reserve in stable coronary artery disease.

Aikawa T, Naya M, Obara M, Manabe O, Magota K, Koyanagawa K, Asakawa N, Ito YM, Shiga T, Katoh C, Anzai T, Tsutsui H, Murthy VL, Tamaki N.

Cardiovasc Res. 2019 Jan 1;115(1):119-129. doi: 10.1093/cvr/cvy169.

13.

Mitochondrial inhibitory factor protein 1 attenuates coupling factor 6-induced aging signal.

Osanai T, Tanaka M, Mikami K, Kitajima M, Magota K, Tomita H, Okumura K.

J Cell Biochem. 2018 Jul;119(7):6194-6203. doi: 10.1002/jcb.26828. Epub 2018 Mar 25.

PMID:
29575130
14.

Quantification of myocardial blood flow with 11C-hydroxyephedrine dynamic PET: comparison with 15O-H2O PET.

Hiroshima Y, Manabe O, Naya M, Tomiyama Y, Magota K, Obara M, Aikawa T, Oyama-Manabe N, Yoshinaga K, Hirata K, Kroenke M, Tamaki N, Katoh C.

J Nucl Cardiol. 2017 Dec 21. doi: 10.1007/s12350-017-1140-4. [Epub ahead of print]

PMID:
29270771
15.

Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction: 11C-hydroxyephedrine PET study.

Aikawa T, Naya M, Obara M, Oyama-Manabe N, Manabe O, Magota K, Ito YM, Katoh C, Tamaki N.

Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1897-1905. doi: 10.1007/s00259-017-3760-y. Epub 2017 Jun 26.

16.

Scatter Correction with Combined Single-Scatter Simulation and Monte Carlo Simulation Scaling Improved the Visual Artifacts and Quantification in 3-Dimensional Brain PET/CT Imaging with 15O-Gas Inhalation.

Magota K, Shiga T, Asano Y, Shinyama D, Ye J, Perkins AE, Maniawski PJ, Toyonaga T, Kobayashi K, Hirata K, Katoh C, Hattori N, Tamaki N.

J Nucl Med. 2017 Dec;58(12):2020-2025. doi: 10.2967/jnumed.117.193060. Epub 2017 Jun 23.

17.

PET/CT scanning with 3D acquisition is feasible for quantifying myocardial blood flow when diagnosing coronary artery disease.

Manabe O, Naya M, Aikawa T, Obara M, Magota K, Kroenke M, Oyama-Manabe N, Hirata K, Shinyama D, Katoh C, Tamaki N.

EJNMMI Res. 2017 Dec;7(1):52. doi: 10.1186/s13550-017-0296-x. Epub 2017 Jun 5.

18.

Nutritional regulation of coupling factor 6, a novel vasoactive and proatherogenic peptide.

Osanai T, Mikami K, Kitajima M, Urushizaka M, Kawasaki K, Tomisawa T, Itaki C, Noto Y, Magota K, Tomita H.

Nutrition. 2017 May;37:74-78. doi: 10.1016/j.nut.2016.07.017. Epub 2016 Aug 6. Review.

PMID:
28359367
19.

Impaired Myocardial Sympathetic Innervation Is Associated with Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction: 11C-Hydroxyephedrine PET Study.

Aikawa T, Naya M, Obara M, Manabe O, Tomiyama Y, Magota K, Yamada S, Katoh C, Tamaki N, Tsutsui H.

J Nucl Med. 2017 May;58(5):784-790. doi: 10.2967/jnumed.116.178558. Epub 2016 Nov 3.

20.

The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.

Okamoto S, Shiga T, Yasuda K, Watanabe S, Hirata K, Nishijima KI, Magota K, Kasai K, Onimaru R, Tuchiya K, Kuge Y, Shirato H, Tamaki N.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2147-2154. Epub 2016 Jun 1.

PMID:
27251644
21.

New method for accurate estimations of LV function for small hearts.

Magota K, Tamaki N.

J Nucl Cardiol. 2017 Aug;24(4):1393-1394. doi: 10.1007/s12350-016-0548-6. Epub 2016 Jun 1. No abstract available.

PMID:
27251141
22.

Effect of Attenuation Correction on Regional Quantification Between PET/MR and PET/CT: A Multicenter Study Using a 3-Dimensional Brain Phantom.

Teuho J, Johansson J, Linden J, Hansen AE, Holm S, Keller SH, Delso G, Veit-Haibach P, Magota K, Saunavaara V, Tolvanen T, Teräs M, Iida H.

J Nucl Med. 2016 May;57(5):818-24. doi: 10.2967/jnumed.115.166165. Epub 2016 Jan 28.

23.

Mitochondrial Inhibitory Factor Protein 1 Functions as an Endogenous Inhibitor for Coupling Factor 6.

Kawai M, Osanai T, Tanaka M, Magota K, Tomita H, Okumura K.

J Cell Biochem. 2016 Jul;117(7):1680-7. doi: 10.1002/jcb.25461. Epub 2016 Jan 15.

PMID:
26659871
24.

Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart.

Masuda A, Naya M, Manabe O, Magota K, Yoshinaga K, Tsutsui H, Tamaki N.

Acta Radiol. 2016 Jun;57(6):661-8. doi: 10.1177/0284185115600916. Epub 2015 Sep 2.

25.

Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.

Manabe O, Hattori N, Yamaguchi S, Hirata K, Kobayashi K, Terasaka S, Kobayashi H, Motegi H, Shiga T, Magota K, Oyama-Manabe N, Nishijima K, Kuge Y, Tamaki N.

Eur J Nucl Med Mol Imaging. 2015 May;42(6):896-904. doi: 10.1007/s00259-015-2996-7. Epub 2015 Feb 3.

PMID:
25647076
26.

Postoperative assessment of hepatic asialoglycoprotein receptor function with Tc-99m GSA: the safety margin of resection size in living donor liver transplantation.

Kobayashi K, Hattori N, Manabe O, Hirata K, Magota K, Shimamura T, Tamaki N.

Ann Transplant. 2015 Jan 26;20:51-8. doi: 10.12659/AOT.892490.

27.

FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer.

Sudo S, Hattori N, Manabe O, Kato F, Mimura R, Magota K, Sugimori H, Hirata K, Sakuragi N, Tamaki N.

Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):676-84. doi: 10.1007/s00259-014-2964-7. Epub 2014 Dec 13.

PMID:
25504022
28.

Improved spillover correction model to quantify myocardial blood flow by 11C-acetate PET: comparison with 15O-H 2O PET.

Mori Y, Manabe O, Naya M, Tomiyama Y, Yoshinaga K, Magota K, Oyama-Manabe N, Hirata K, Tsutsui H, Tamaki N, Katoh C.

Ann Nucl Med. 2015 Jan;29(1):15-20. doi: 10.1007/s12149-014-0904-z. Epub 2014 Sep 11.

29.

18F-FDG-PET/CT better localizes active spinal infection than MRI for successful minimally invasive surgery.

Nakahara M, Ito M, Hattori N, Magota K, Takahata M, Nagahama K, Sudo H, Kamishima T, Tamaki N, Iwasaki N.

Acta Radiol. 2015 Jul;56(7):829-36. doi: 10.1177/0284185114541983. Epub 2014 Jul 30.

PMID:
25080515
30.

Prone-position acquisition of myocardial (123)I-metaiodobenzylguanidine (MIBG) SPECT reveals regional uptake similar to that found using (11)C-hydroxyephedrine PET/CT.

Yoshinaga K, Tomiyama Y, Manabe O, Kasai K, Katoh C, Magota K, Suzuki E, Nishijima K, Kuge Y, Ito YM, Tamaki N.

Ann Nucl Med. 2014 Oct;28(8):761-9. doi: 10.1007/s12149-014-0868-z. Epub 2014 Jun 21.

PMID:
24950751
31.

Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis.

Manabe O, Yoshinaga K, Ohira H, Sato T, Tsujino I, Yamada A, Oyama-Manabe N, Masuda A, Magota K, Nishimura M, Tamaki N.

Ann Nucl Med. 2014 Aug;28(7):656-63. doi: 10.1007/s12149-014-0860-7. Epub 2014 Jun 3.

PMID:
24889126
32.

Coupling factor 6 attenuates CXCR4 expression through the HIF-1α and c-Src pathways and promotes endothelial apoptosis and inflammation.

Suzuki A, Osanai T, Tanaka M, Tomita H, Magota K, Okumura K.

Hypertens Res. 2014 Aug;37(8):708-15. doi: 10.1038/hr.2014.65. Epub 2014 Mar 20.

PMID:
24646644
33.

Electrocardiographically gated ¹¹C-hydroxyephedrine PET for the simultaneous assessment of cardiac sympathetic and contractile functions.

Magota K, Hattori N, Manabe O, Naya M, Oyama-Manabe N, Shiga T, Kuge Y, Yamada S, Sakakibara M, Yoshinaga K, Tamaki N.

Ann Nucl Med. 2014 Apr;28(3):187-95. doi: 10.1007/s12149-013-0795-4. Epub 2013 Dec 10.

PMID:
24323747
34.

123I-iomazenil single photon emission computed tomography visualizes recovery of neuronal integrity by bone marrow stromal cell therapy in rat infarct brain.

Saito H, Magota K, Zhao S, Kubo N, Kuge Y, Shichinohe H, Houkin K, Tamaki N, Kuroda S.

Stroke. 2013 Oct;44(10):2869-74. doi: 10.1161/STROKEAHA.113.001612. Epub 2013 Jul 23.

PMID:
23881961
35.

Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.

Saito H, Kuroda S, Hirata K, Magota K, Shiga T, Tamaki N, Yoshida D, Terae S, Nakayama N, Houkin K.

Cerebrovasc Dis. 2013;35(4):370-7. doi: 10.1159/000348846. Epub 2013 Apr 30.

PMID:
23635390
36.

Coupling factor 6 enhances the spontaneous microaggregation of platelets by decreasing cytosolic cAMP irrespective of antiplatelet therapy.

Sukekawa T, Osanai T, Nishizaki F, Metoki N, Hagii J, Kamada T, Yasujima M, Tomita H, Magota K, Okumura K.

Hypertens Res. 2013 Jun;36(6):520-7. doi: 10.1038/hr.2012.231. Epub 2013 Feb 7.

PMID:
23388886
37.

High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.

Okamoto S, Shiga T, Yasuda K, Ito YM, Magota K, Kasai K, Kuge Y, Shirato H, Tamaki N.

J Nucl Med. 2013 Feb;54(2):201-7. doi: 10.2967/jnumed.112.109330. Epub 2013 Jan 15.

38.

Bone marrow stromal cell transplantation enhances recovery of local glucose metabolism after cerebral infarction in rats: a serial 18F-FDG PET study.

Miyamoto M, Kuroda S, Zhao S, Magota K, Shichinohe H, Houkin K, Kuge Y, Tamaki N.

J Nucl Med. 2013 Jan;54(1):145-50. doi: 10.2967/jnumed.112.109017. Epub 2012 Nov 30.

39.

A novel PET scanner with semiconductor detectors may improve diagnostic accuracy in the metastatic survey of head and neck cancer patients.

Takei T, Shiga T, Morimoto Y, Takeuchi W, Umegaki K, Matsuzaki K, Okamoto S, Magota K, Hara T, Fukuda S, Tamaki N.

Ann Nucl Med. 2013 Jan;27(1):17-24. doi: 10.1007/s12149-012-0654-8. Epub 2012 Nov 3.

PMID:
23124525
40.

¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.

Hirata K, Terasaka S, Shiga T, Hattori N, Magota K, Kobayashi H, Yamaguchi S, Houkin K, Tanaka S, Kuge Y, Tamaki N.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):760-70. doi: 10.1007/s00259-011-2037-0. Epub 2012 Feb 4.

41.

Overexpression of coupling factor 6 attenuates exercise-induced physiological cardiac hypertrophy by inhibiting PI3K/Akt signaling in mice.

Sagara S, Osanai T, Itoh T, Izumiyama K, Shibutani S, Hanada K, Yokoyama H, Yamamoto Y, Yokota T, Tomita H, Magota K, Okumura K.

J Hypertens. 2012 Apr;30(4):778-86. doi: 10.1097/HJH.0b013e3283505101.

PMID:
22306848
42.

Estrogen attenuates coupling factor 6-induced salt-sensitive hypertension and cardiac systolic dysfunction in mice.

Izumiyama K, Osanai T, Sagara S, Yamamoto Y, Itoh T, Sukekawa T, Nishizaki F, Magota K, Okumura K.

Hypertens Res. 2012 May;35(5):539-46. doi: 10.1038/hr.2011.232. Epub 2012 Jan 19.

PMID:
22258022
43.

Coupling factor 6-induced activation of ecto-F1F(o) complex induces insulin resistance, mild glucose intolerance and elevated blood pressure in mice.

Osanai T, Tanaka M, Magota K, Tomita H, Okumura K.

Diabetologia. 2012 Feb;55(2):520-9. doi: 10.1007/s00125-011-2341-z. Epub 2011 Oct 25.

PMID:
22038518
44.

Dynamic 11C-methionine PET analysis has an additional value for differentiating malignant tumors from granulomas: an experimental study using small animal PET.

Zhao S, Kuge Y, Yi M, Zhao Y, Hatano T, Magota K, Nishijima K, Kohanawa M, Tamaki N.

Eur J Nucl Med Mol Imaging. 2011 Oct;38(10):1876-86. doi: 10.1007/s00259-011-1865-2. Epub 2011 Jul 6.

45.

Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging.

Magota K, Kubo N, Kuge Y, Nishijima K, Zhao S, Tamaki N.

Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):742-52. doi: 10.1007/s00259-010-1683-y. Epub 2010 Dec 10.

46.

Overexpression of coupling factor 6 causes cardiac dysfunction under high-salt diet in mice.

Ashitate T, Osanai T, Tanaka M, Magota K, Echizen T, Izumiyama K, Yokoyama H, Shibutani S, Hanada K, Tomita H, Okumura K.

J Hypertens. 2010 Nov;28(11):2243-51. doi: 10.1097/HJH.0b013e32833dfcbe.

PMID:
20811295
47.

Novel pro-atherogenic molecule coupling factor 6 is elevated in patients with stroke: a possible linkage to homocysteine.

Osanai T, Fujiwara N, Sasaki S, Metoki N, Saitoh G, Tomita H, Nishimura T, Shibutani S, Yokoyama H, Konta Y, Magota K, Okumura K.

Ann Med. 2010;42(1):79-86. doi: 10.3109/07853890903451781.

PMID:
20092401
48.

Coupling factor 6 as a novel vasoactive and proatherogenic peptide in vascular endothelial cells.

Osanai T, Magota K, Okumura K.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Sep;380(3):205-14. doi: 10.1007/s00210-009-0431-y. Epub 2009 Jun 2. Review.

PMID:
19488738
49.

Coupling factor 6-induced prostacyclin inhibition is enhanced in vascular smooth muscle cells from spontaneously hypertensive rats.

Osanai T, Tomita H, Yamada M, Tanaka M, Ashitate T, Echizen T, Katoh C, Magota K, Okumura K.

J Hypertens. 2009 Sep;27(9):1823-8. doi: 10.1097/HJH.0b013e32832d4b05.

PMID:
19474762
50.

Upregulation of soluble vascular endothelial growth factor receptor type 1 by endogenous prostacyclin inhibitor coupling factor 6 in vascular endothelial cells: a role of acidosis-induced c-Src activation.

Echizen T, Osanai T, Ashitate T, Yokoyama H, Shibutani S, Tanaka M, Tomita H, Magota K, Okumura K.

Hypertens Res. 2009 Mar;32(3):182-7. doi: 10.1038/hr.2008.24. Epub 2009 Jan 16.

PMID:
19262480

Supplemental Content

Loading ...
Support Center